Aytu BioPharma, Inc.

AYTU·NasdaqCM
Compare
1.9700−0.0550 (−2.72%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.0250
Open1.9900
Day range1.96002.0300
52-week range1.80003.0700
Off day high−2.96%
Off 52-week high−35.83%
Volume23.25K
Avg. volume (3M)34.17K
Market cap21.41M
EPS (TTM)-1.16
Forward P/E12.71
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding10.87M
Short interest—
Earnings dateMay 14, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
AYTU AQST UPC CPHI IXHL DERM
Market cap 21.41M 603.71M 20.75M 37.39M 36.38M 166.81M
P/E (TTM) — — — — — —
Forward P/E 12.7 -8.4 — — -1.7 -98.5
Price/book 0.6 -10.7 0.0 1.0 0.5 5.1
Dividend yield — — — — — —
1-year change −17.23% −30.09% −30.83% −53.23% −74.67% −9.86%
Today −2.72% +0.63% −0.48% −0.17% −6.45% −6.34%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All AYTU news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.